Dominick J Angiolillo, Fernando Alfonso. Show Affiliations »
Abstract
Entities: Chemical
Mesh： See more » Cardiovascular Diseases/drug therapyCardiovascular Diseases/metabolismClopidogrelCytochrome P-450 CYP3ACytochrome P-450 Enzyme System/metabolismDose-Response Relationship, DrugDrug InteractionsDrug Therapy, CombinationHumansHydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosageHydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effectsHydroxymethylglutaryl-CoA Reductase Inhibitors/metabolismPlatelet Aggregation Inhibitors/administration & dosagePlatelet Aggregation Inhibitors/adverse effectsPlatelet Aggregation Inhibitors/metabolismTiclopidine/administration & dosageTiclopidine/adverse effectsTiclopidine/analogs & derivativesTiclopidine/metabolism
Substances： See more » Hydroxymethylglutaryl-CoA Reductase InhibitorsPlatelet Aggregation InhibitorsCytochrome P-450 Enzyme SystemClopidogrelCYP3A protein, humanCytochrome P-450 CYP3ATiclopidine
Year: 2007 PMID： 17659195 DOI： 10.1016/j.jacc.2007.04.041
Source DB: PubMed Journal: J Am Coll Cardiol ISSN： 0735-1097 Impact factor: 24.094